Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

about

Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives

P2860

Q57071456-563F2F20-2414-4DDA-B2E2-F6280D116076

P2860

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

Item

http://www.wikidata.org/entity/Q43995291

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

@en

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

@nl

type

Item

label

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

@en

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

@nl

prefLabel

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

@en

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

@nl

P1476

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis

@en

P2093

Carlo Vancheri

http://www.w3.org/2001/XMLSchema#string

Elisabetta Renzoni

http://www.w3.org/2001/XMLSchema#string

Mirjam J G van Manen

http://www.w3.org/2001/XMLSchema#string

Monique Wapenaar

http://www.w3.org/2001/XMLSchema#string

Surinder S Birring

http://www.w3.org/2001/XMLSchema#string

Virginia Vindigni

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study

Objective cough frequency in Idiopathic Pulmonary Fibrosis.

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment

Cough predicts prognosis in idiopathic pulmonary fibrosis.

A study of the cough reflex in idiopathic pulmonary fibrosis.

Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis.

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.

Stretch-induced Activation of Transforming Growth Factor-β1 in Pulmonary Fibrosis.

Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial.

Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors.

P31

scholarly article

P356

10.1183/13993003.01157-2017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vincent Cottin

Anne-Marie Russell

Marlies Wijsenbeek

P577

2017-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29051272

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

5678896

http://www.w3.org/2001/XMLSchema#string

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

about

P2860

P2860

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932